EUVIMEDEUVIMED entdecken
Kohortenstudie

Is Myomectomy Safe during Cesarean Section - A Prospective Cohort Study

European Journal of Clinical Pharmacy · 31.12.2025 · 7 (1) · 6818-6824

DOI: 10.61336/ejcp/25-08-414 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 31.12.2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cesarean myomectomy has been traditionally avoided because of the risk of bleeding but there is new evidence which supports the safety of this procedure in the chosen patients.

Objectives

To assess the safety of Myomectomy during Cesarean Section.

Methods

The study was a prospective cohort study that was carried out at the Department of Obstetrics and Gynecology, Memon Medical Institute Hospital, in a Three Months after the approval of this study by CPSP. Non-probability consecutive sampling was used to select 73 women aged 18-45 years who were undergoing cesarean section with concurrent myomectomy. The participants were stratified in terms of the estimated blood loss (less than 1000 mL and 1000 mL and more). Statistical analysis was done in SPSS version 24.0, and p 0.05 was taken to be significant.

Results

The average maternal age was 32.4 ±5.6 years. The size of the fibroid was also significantly related to the amount of blood loss (6.8 cm vs. 5.5 cm, p = 0.04), but not the number and location of the fibroid. Women who lost 1000mL blood lost (6.8) had much more hemoglobin drop (2.5 ± 0.3 vs. 1.1 ± 0.5 g/dL, p < 0.001), lower postoperative hemoglobin (9.3 ± 0.7 vs. 10.9 ± 0.8 g/dL, p < 0.001), and all needed blood transfusion (p < 0.001).

Conclusion

Cesarean myomectomy is a safe procedure in the majority of patients and it has no significant blood loss. The bigger the size of a fibroid, the more likely it is to cause serious bleeding.

Zitieren

APA

(2025). Is Myomectomy Safe during Cesarean Section - A Prospective Cohort Study. European Journal of Clinical Pharmacy, 7(1), 6818-6824. https://doi.org/10.61336/ejcp/25-08-414

Vancouver

Is Myomectomy Safe during Cesarean Section - A Prospective Cohort Study. European Journal of Clinical Pharmacy. 2025;7(1):6818-6824. doi:10.61336/ejcp/25-08-414

BibTeX
@article{euvimed2025,
  title = {Is Myomectomy Safe during Cesarean Section - A Prospective Cohort Study},
  journal = {European Journal of Clinical Pharmacy},
  year = {2025},
  volume = {7},
  number = {1},
  pages = {6818--6824},
  doi = {10.61336/ejcp/25-08-414}
}
Kostenlos starten →